Balchem BCPC Human Nutrition and Health — D&A
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Balchem in its filing.
Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.
The official record: Balchem’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Balchem's human nutrition and health — d&a.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Balchem's human nutrition and health — D&A?
- Balchem (BCPC) reported human nutrition and health — D&A of $8.65M in Q1 2026.
- How has Balchem's human nutrition and health — D&A changed year-over-year?
- Balchem's human nutrition and health — D&A increased by 18.4% year-over-year, from $7.3M to $8.65M.
- What is the long-term trend for Balchem's human nutrition and health — D&A?
- Over 4 years (2021 to 2025), Balchem's human nutrition and health — D&A has grown at a 0.1% compound annual growth rate (CAGR), from $30.01M to $30.12M.
- What does human nutrition and health — D&A mean?
- Reflects the systematic allocation of the cost of tangible and intangible assets over their useful lives within the Human Nutrition and Health segment. This non-cash expense is essential for understanding the segment's capital maintenance requirements and true operational cash flow. It provides insight into the segment's investment in long-term infrastructure and intellectual property.